ARTA
SGNT

A.R.T. Advisors’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

A.R.T. Advisors’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-22,994
Closed -$279K – 1851
2016
Q1 		$279K Buy
22,994
+100
+0.4% +$1.4K 0.01% 1065
2015
Q4 		$364K Sell
22,894
-1,200
-5% -$18.9K 0.02% 984
2015
Q3 		$369K Sell
24,094
-31,593
-57% -$683K 0.01% 974
2015
Q2 		$1.35M Buy
55,687
+16,804
+43% +$403K 0.05% 612
2015
Q1 		$904K Buy
38,883
+839
+2% +$22.2K 0.03% 698
2014
Q4 		$955K Buy
+38,044
New +$1.12M 0.04% 662
2014
Q2 		– Sell
-34,719
Closed -$811K – 1702
2014
Q1 		$811K Buy
34,719
+9,297
+37% +$203K 0.04% 574
2013
Q4 		$645K Sell
25,422
-20,634
-45% -$466K 0.03% 670
2013
Q3 		$939K Buy
46,056
+25,254
+121% +$562K 0.05% 529
2013
Q2 		$436K Buy
+20,802
New +$372K 0.01% 927

Other funds holding SGNT

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

A.R.T. Advisors's SGNT Position: Q2 2016 in Review

A.R.T. Advisors sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q2 2016, closing a stake of 22,994 shares — an estimated $279K sold.

A.R.T. Advisors first reported a position in SGNT in Q2 2013 and held it in 10 quarters. The position peaked at $1.35M in Q2 2015. 128 funds tracked by Wall St. Rank hold SGNT as of Q2 2016.

  • A.R.T. Advisors reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • A.R.T. Advisors sold 22,994 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q2 2016, an estimated $279K.
  • A.R.T. Advisors first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 10 quarters.
  • A.R.T. Advisors's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $1.35M in Q2 2015.
  • 128 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q2 2016.

Based on A.R.T. Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.